Price Alert

Lineage Inc. (LINE)

NASDAQ: LINE · Real-Time Price · USD

41.79

-0.60 (-1.42%)

At close: Sep 12, 2025, 3:59 PM

42.18

0.93%

Pre-market: Sep 15, 2025, 07:00 AM EDT

-1.42% (1D)

Bid	41
Market Cap	9.56B
Revenue (ttm)	5.32B
Net Income (ttm)	-562M
EPS (ttm)	-2.4
PE Ratio (ttm)	-17.41
Forward PE	-1398.67
Analyst	Hold

Ask	44.9
Volume	1,145,793
Avg. Volume (20D)	1,089,125
Open	42.24
Previous Close	42.39
Day's Range	41.06 - 42.35
52-Week Range	38.83 - 84.86
Beta	-0.19

About LINE

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol LINE

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for LINE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Lineage Inc. is scheduled to release its earnings on Nov 5, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 month ago

-4.23%

Lineage shares are trading lower after Piper Sandl... Unlock content with Pro Subscription

4 months ago

-14.62%

Lineage shares are trading lower after the company reported worse-than-expected Q1 sales results.

News

3 days ago · businesswire.com

Lineage, Inc. Declares Dividend for Third Quarter 2025

NOVI, Mich.--(BUSINESS WIRE)--Lineage, Inc. (NASDAQ: LINE) (the "Company"), the world's largest global temperature-controlled warehouse REIT, today announced that its Board of Directors has declared a...

4 days ago · businesswire.com

LINEAGE, INC. INVESTOR ALERT: Kirby McInerney LLP Reminds Lineage, Inc. Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit

NEW YORK--(BUSINESS WIRE)--If you have suffered a loss on your Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ:LINE) investment, contact Thomas W. Elrod of Kirby McInerney LLP by email at investiga...

6 days ago · businesswire.com

Lineage Cell Therapeutics Initiates Cell Transplant Program In Type 1 Diabetes

CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic...

1 week ago · businesswire.com

Lineage Cell Therapeutics to Present at September 2025 Investor Conferences

1 week ago · seekingalpha.com

The Calm Before The Cut

U.S. equity markets were little-changed this past week as a tranquil end-of-summer week with status-quo inflation and economic indicators concluded with a jolting post-close tariff headline with highl...

3 weeks ago · seekingalpha.com

Lineage: Cold Storage And A 5.2% Dividend Yield

Lineage has dipped by nearly 60% over the last one year, due to a perfect storm of headwinds for the temperature-controlled warehouse owner and operator. The REIT is paying out a 5.2% dividend yield t...

3 weeks ago · businesswire.com

Lineage and Port of New Orleans Collaborate to Expand Bonded Warehouse Space, Strengthening Global Trade Flows

NEW ORLEANS--(BUSINESS WIRE)-- #oneLineage--Lineage's Jourdan Road cold storage facility in New Orleans now offers both I-House capabilities and customs bonded space.